# A Study to Investigate the Efficacy and Safety of Apraglutide Compared With Placebo in Adult Participants With Short Bowel Syndrome Associated With Intestinal Failure (SBS-IF)

> **NCT07742735** · PHASE3 · RECRUITING · sponsor: **VectivBio AG** · enrollment: 124 (estimated)

## Conditions studied

- Short Bowel Syndrome (SBS)
- SBS Associated With Intestinal Failure (SBS-IF)

## Interventions

- **DRUG:** Apraglutide
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT07742735
- **Lead sponsor:** VectivBio AG
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-08
- **Primary completion:** 2028-10
- **Final completion:** 2029-10
- **Target enrollment:** 124 (ESTIMATED)
- **Last updated:** 2026-08-04

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07742735

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07742735, "A Study to Investigate the Efficacy and Safety of Apraglutide Compared With Placebo in Adult Participants With Short Bowel Syndrome Associated With Intestinal Failure (SBS-IF)". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07742735. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*